| 000 | 00958 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518032323.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a1178-7007 | ||
| 024 | 7 |
_a10.2147/DMSO.S194410 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHodeib, Hossam | |
| 245 | 0 | 0 |
_aGalectin-3 as a prognostic biomarker for diabetic nephropathy. _h[electronic resource] |
| 260 |
_bDiabetes, metabolic syndrome and obesity : targets and therapy _c2019 |
||
| 300 |
_a325-331 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aHagras, Maha M | |
| 700 | 1 | _aAbdelhai, Dina | |
| 700 | 1 | _aWatany, Mona M | |
| 700 | 1 | _aSelim, Amal | |
| 700 | 1 | _aTawfik, Mohamed A | |
| 700 | 1 | _aElsebaey, Mohamed A | |
| 700 | 1 | _aElshweikh, Samah A | |
| 773 | 0 |
_tDiabetes, metabolic syndrome and obesity : targets and therapy _gvol. 12 _gp. 325-331 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/DMSO.S194410 _zAvailable from publisher's website |
| 999 |
_c29541498 _d29541498 |
||